Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to $541000.0.

  • Abeona Therapeutics' Other Non-Current Assets rose 6005.92% to $541000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $541000.0, marking a year-over-year increase of 6005.92%. This contributed to the annual value of $338000.0 for FY2024, which is 0.0% changed from last year.
  • Per Abeona Therapeutics' latest filing, its Other Non-Current Assets stood at $541000.0 for Q3 2025, which was up 6005.92% from $338000.0 recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Other Non-Current Assets ranged from a high of $5.9 million in Q4 2021 and a low of $338000.0 during Q4 2022
  • For the 5-year period, Abeona Therapeutics' Other Non-Current Assets averaged around $1.6 million, with its median value being $338000.0 (2022).
  • Examining YoY changes over the last 5 years, Abeona Therapeutics' Other Non-Current Assets showed a top increase of 50420.51% in 2022 and a maximum decrease of 9426.24% in 2022.
  • Quarter analysis of 5 years shows Abeona Therapeutics' Other Non-Current Assets stood at $5.9 million in 2021, then tumbled by 94.26% to $338000.0 in 2022, then changed by 0.0% to $338000.0 in 2023, then changed by 0.0% to $338000.0 in 2024, then skyrocketed by 60.06% to $541000.0 in 2025.
  • Its Other Non-Current Assets was $541000.0 in Q3 2025, compared to $338000.0 in Q2 2025 and $338000.0 in Q1 2025.